Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus: A Continuation of a Seventy-Six-Week Phase III Parent Study in the United States - Furie, R A; Wallace, D J; Aranow, C (Arthritis Rheumatol, 2018)
et al.